Pharmacokinetic Assessments of Ursolic Loaded-Dendrimer Complex

IF 0.7 4区 医学 Q4 PHARMACOLOGY & PHARMACY Current Pharmaceutical Analysis Pub Date : 2024-08-29 DOI:10.2174/0115734129300077240813063934
Aditya Singh, Vaseem Ahamad Ansari, Tarique Mahmood Ansari, Rufaida Wasim, Juber Akhtar, Shubhrat Maheshwari
{"title":"Pharmacokinetic Assessments of Ursolic Loaded-Dendrimer Complex","authors":"Aditya Singh, Vaseem Ahamad Ansari, Tarique Mahmood Ansari, Rufaida Wasim, Juber Akhtar, Shubhrat Maheshwari","doi":"10.2174/0115734129300077240813063934","DOIUrl":null,"url":null,"abstract":"Background: This study investigates the application of polyamidoamine (PAMAM) dendrimers as an innovative drug delivery approach for enhancing the pharmacokinetic profile of ursolic acid (UA), a pentacyclic triterpenoid with multifaceted therapeutic properties. UA, sourced from plants like Sanguisorba officinalis and Salvia officinalis, has been extensively studied for its pharmacological characteristics, including anti-inflammatory, antioxidant, and anti-diabetic properties, as recognized in Traditional Chinese Medicine (TCM). The clinical utility of UA is hampered by low bioavailability, which is attributed to its hydrophobic nature. To address this limitation, we explore the use of PAMAM dendrimers, known for their drug delivery potential. Methods: The UA-PAMAM G0 dendrimers were synthesized with varying molar ratios. Characterization included size analysis, PDI, and zeta potential determination. FTIR confirmed the chemical structure. Male Wistar rats were acclimatized and administered UA control suspension and UA-G0 dendrimer complex orally. Blood samples were collected for pharmacokinetic analysis. The study obtained IAEC approval. Results: The UA-PAMAM G0 dendrimer complexes exhibited varying sizes based on molar ratios, with the 2:1 ratio showing significantly smaller dimensions. FTIR confirmed successful conjugation. In the pharmacokinetic study, the UA-G0 dendrimer complex demonstrated higher plasma concentrations than UA alone, as indicated by increased Cmax and AUC values. The results suggest enhanced oral delivery and bioavailability of UA in the dendrimer complex. Conclusion: This study demonstrated the successful synthesis of UA-PAMAM G0 dendrimer complexes with size variations based on molar ratios. The pharmacokinetic analysis revealed improved plasma concentrations and bioavailability of UA in the dendrimer complex compared to UA alone. These findings highlight the potential of PAMAM dendrimers for enhancing the oral delivery of hydrophobic compounds like UA, bridging the gap between traditional herbal medicine and modern drug delivery strategies. Further research can explore the broader applications of such dendrimer complexes in drug delivery systems.","PeriodicalId":10889,"journal":{"name":"Current Pharmaceutical Analysis","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmaceutical Analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734129300077240813063934","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study investigates the application of polyamidoamine (PAMAM) dendrimers as an innovative drug delivery approach for enhancing the pharmacokinetic profile of ursolic acid (UA), a pentacyclic triterpenoid with multifaceted therapeutic properties. UA, sourced from plants like Sanguisorba officinalis and Salvia officinalis, has been extensively studied for its pharmacological characteristics, including anti-inflammatory, antioxidant, and anti-diabetic properties, as recognized in Traditional Chinese Medicine (TCM). The clinical utility of UA is hampered by low bioavailability, which is attributed to its hydrophobic nature. To address this limitation, we explore the use of PAMAM dendrimers, known for their drug delivery potential. Methods: The UA-PAMAM G0 dendrimers were synthesized with varying molar ratios. Characterization included size analysis, PDI, and zeta potential determination. FTIR confirmed the chemical structure. Male Wistar rats were acclimatized and administered UA control suspension and UA-G0 dendrimer complex orally. Blood samples were collected for pharmacokinetic analysis. The study obtained IAEC approval. Results: The UA-PAMAM G0 dendrimer complexes exhibited varying sizes based on molar ratios, with the 2:1 ratio showing significantly smaller dimensions. FTIR confirmed successful conjugation. In the pharmacokinetic study, the UA-G0 dendrimer complex demonstrated higher plasma concentrations than UA alone, as indicated by increased Cmax and AUC values. The results suggest enhanced oral delivery and bioavailability of UA in the dendrimer complex. Conclusion: This study demonstrated the successful synthesis of UA-PAMAM G0 dendrimer complexes with size variations based on molar ratios. The pharmacokinetic analysis revealed improved plasma concentrations and bioavailability of UA in the dendrimer complex compared to UA alone. These findings highlight the potential of PAMAM dendrimers for enhancing the oral delivery of hydrophobic compounds like UA, bridging the gap between traditional herbal medicine and modern drug delivery strategies. Further research can explore the broader applications of such dendrimer complexes in drug delivery systems.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
熊果酸负载树枝状复合物的药代动力学评估
背景:本研究调查了聚酰胺胺(PAMAM)树枝状聚合物作为一种创新的给药方法在增强熊果酸(UA)药代动力学特征方面的应用。熊果酸来源于三七和丹参等植物,其药理特性已得到广泛研究,包括抗炎、抗氧化和抗糖尿病特性,这一点已得到传统中医的认可。尿囊素的疏水性导致其生物利用率较低,从而影响了其临床应用。为解决这一局限性,我们探索了 PAMAM 树枝状聚合物的使用方法,众所周知,PAMAM 树枝状聚合物具有药物输送潜力。方法:以不同的摩尔比合成了 UA-PAMAM G0 树枝状聚合物。表征包括尺寸分析、PDI 和 zeta 电位测定。傅立叶变换红外光谱确认了化学结构。雄性 Wistar 大鼠适应环境后,口服 UA 对照悬浮液和 UA-G0 树枝状聚合物复合物。收集血液样本用于药代动力学分析。该研究已获得 IAEC 批准。研究结果根据摩尔比,UA-PAMAM G0 树枝状聚合物复合物显示出不同的尺寸,其中 2:1 比率的尺寸明显较小。傅立叶变换红外光谱证实共轭成功。在药代动力学研究中,UA-G0 树枝状聚合物复合物的血浆浓度高于单独的 UA,表现为 Cmax 值和 AUC 值增加。结果表明,树枝状聚合物复合物提高了尿酸的口服给药和生物利用度。结论本研究成功合成了 UA-PAMAM G0 树枝状聚合物复合物,并根据摩尔比进行了尺寸变化。药代动力学分析表明,与单独使用 UA 相比,树枝状聚合物复合物中 UA 的血浆浓度和生物利用度均有所提高。这些发现凸显了 PAMAM 树枝状聚合物在增强 UA 等疏水性化合物口服给药方面的潜力,弥补了传统中药与现代给药策略之间的差距。进一步的研究可以探索此类树枝状聚合物复合物在给药系统中的更广泛应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
85
审稿时长
3 months
期刊介绍: Aims & Scope Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.
期刊最新文献
Simultaneous Estimation of Pregabalin and Duloxetine Used to Treat Nerve Pain by Stability Indicating RP-HPLC Method Using the QBD Approach Research on Compatibility of Packaging Materials of High-Risk Cephalosporin Powder Injection and Establishment of Indicator Component Evaluation Method Universally Applicable Methods for Comprehensive Risk Assessment of Elemental Impurities in Vitamin A and D Preparations An Overview of Biotechnological Drug’s Various Techniques of Downstream Process, Guideline’s And Different Chromatographic Analysis Validation of GF-AAS Method for the Determination of Aluminium Content in Human Albumin Finished Product
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1